DAC treatment increased the expression level of various tumor antigens in cells, the conjugated SZU-106 activated the TLR7 signaling both in DC cells to promote antigen-presenting, and in cytotoxic T cells to promote the secretion of pro-inflammatory cytokines. The gene discussed is TLR7; the disease is neoplasm.